Journal article

Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies

Abstract:: Background Change in albuminuria as a surrogate endpoint for progression of chronic kidney disease is strongly supported by biological plausibility, but empirical evidence to support its validity in epidemiological studies is lacking. We aimed to assess the consistency of the association between change in albuminuria and risk of end-stage kidney disease in a large individual participant-level meta-analysis of observational studies. Methods In this meta-analy... Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Coresh, J., Heerspink, H., Sang, Y., Woodward, M., & al., E. (2019). Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies. Lancet Diabetes and Endocrinology, 7(2), 115–127.

MLA Style

Coresh, J, et al. “Change in Albuminuria and Subsequent Risk of End-Stage Kidney Disease: an Individual Participant-Level Consortium Meta-Analysis of Observational Studies.” Lancet Diabetes and Endocrinology, vol. 7, no. 2, 2019, pp. 115–27.

Chicago Style

Coresh, J, H Heerspink, Y Sang, M Woodward, and E al. 2019. “Change in Albuminuria and Subsequent Risk of End-Stage Kidney Disease: an Individual Participant-Level Consortium Meta-Analysis of Observational Studies.” Lancet Diabetes and Endocrinology 7 (2): 115–27.
Print

Access Document

Files:: Coresh-et-al-Lancet-Diabetes-and-Endocrinology-AAM.pdf

(Preview, Accepted manuscript, pdf, 414.7KB, Terms of use)

Supplement_ACR.pdf

(Preview, Accepted manuscript, pdf, 801.4KB, Terms of use)

Publisher copy:: 10.1016/S2213-8587(18)30313-9

Authors

+ Coresh, J More by this author

Role:: Author

+ Heerspink, H More by this author

Role:: Author

+ Sang, Y More by this author

Role:: Author

+ Woodward, M More by this author

Institution:: University of Oxford
Division:: Medical Sciences Division
Department:: Women's & Reproductive Health
Sub department:: Women's & Reproductive Health
Department:: Oxford, MSD, Womens & Reproductive Health
Role:: Author

+ al., E More by this author

Role:: Author

+ US National Kidney Foundation More from this funder

+ National Institute of Diabetes and Digestive and Kidney Diseases More from this funder

Publisher:: Elsevier
Journal:: Lancet Diabetes and Endocrinology More from this journal
Volume:: 7
Issue:: 2
Pages:: 115-127
Publication date:: 2019-01-08
Acceptance date:: 2018-10-19
DOI:: 10.1016/S2213-8587(18)30313-9
ISSN:: 2213-8587

Pubs id:: pubs:930061
UUID:: uuid:921c709f-2cae-48b2-8812-0f157c82dc57
Local pid:: pubs:930061
Source identifiers:: 930061
Deposit date:: 2018-10-22
ARK identifier:: ark:/29072/ora_921c709f2cae48b288120f157c82dc57

Terms of use

Copyright holder:: Elsevier Ltd
Copyright date:: 2019
Notes:: Copyright © 2019 Elsevier Ltd. This is the accepted manuscript version of the article. The final version is available online from Elsevier at: https://doi.org/10.1016/S2213-8587(18)30313-9

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP